MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 6191-6200 Newer>
The Motley Fool
February 12, 2010
Brian Orelli
Too Bad It's Not in the "Restructuring" Business Shares of Boston Scientific slipped nearly 10% yesterday, after the company released earnings and guidance for this year. mark for My Articles 264 similar articles
The Motley Fool
February 12, 2010
Rich Smith
This Just In: Upgrades and Downgrades Initiating coverage on the Chinese medical device baker, Deutsche called Mindray "the leader in many of its product areas and a low-cost producer of medical equipment." mark for My Articles 41 similar articles
BusinessWeek
February 11, 2010
Nussbaum & Tirrell
Health Reform Is Dead. Let's Go Shopping Thriving insurers and hospital chains may start to gobble up competitors weakened by the recession. mark for My Articles 297 similar articles
The Motley Fool
February 11, 2010
Brian Orelli
A Wonder Drug With Not-So-Wonderful Side Effects Wonder drug or not, Isis Pharmaceuticals and Genzyme's cholesterol drug mipomersen's sales will be limited by side effects. mark for My Articles 349 similar articles
The Motley Fool
February 11, 2010
Brian Orelli
A Turnaround Year, But Not in a Good Way 2009 was a solid year for sanofi-aventis thanks to a boost from sales of swine flu vaccine and some help from the exchange rate. But 2010? Not so solid. mark for My Articles 775 similar articles
The Motley Fool
February 11, 2010
Rich Smith
American Science Takes Its Lumps Once again, AS&E suffers from lumpy earnings. mark for My Articles 190 similar articles
The Motley Fool
February 11, 2010
Brian Orelli
Blockbuster in Hand, It's Time to Show a Profit Elan predicts an operating profit for the first time in nine years. mark for My Articles 306 similar articles
The Motley Fool
February 10, 2010
Brian Orelli
Icahn's Smiling -- Should We Be? Biogen Idec's fourth quarter results must have made Carl Icahn smile. But the guidance for next year gives pause. mark for My Articles 858 similar articles
The Motley Fool
February 9, 2010
Brian Orelli
What Bipartisan Health-Care Reform Means for Investors Republicans and Democrats will debate on TV, but little may come of it. mark for My Articles 442 similar articles
The Motley Fool
February 9, 2010
Brian Orelli
Pfizer's Slippery Slope Discount cards for drugs help Pfizer track patients' use. mark for My Articles 504 similar articles
<Older 6191-6200 Newer>    Return to current articles.